Elan Pharmaceuticals
Pharmaceutical / Biotechnology
Companies / Elan Pharmaceuticals
0
Latest Hiring Jobs
5
Clinical Trials
0
FDA Products
0
Publications
Company Overview
COMPANY TYPE
Unknown
INDUSTRIES
Unknown
HEADQUARTERS
WEBSITE
Not available
Clinical activity detected
This company has 5 clinical trial records in the intelligence database.
Clinical Development
Recent clinical trial activity
5 Trials
Trial Phase Status Enrollment Start Date Condition
NCT00618267
ATP Expression in Lymphocytes of MS Patients by Means of "ImmuKnow®" Assay.
Observational COMPLETED - - Multiple Sclerosis
NCT00472992
Pregnancy Exposure Registry for Tysabri®
Observational COMPLETED - - Crohn's Disease, Prenatal Exposure
NCT00177736
Pharmacodynamic Parameters of Two Different Doses of Cefepime
Observational COMPLETED - - Infection, Bacteremia
NCT01626248
Analysis of Lymphocyte Cell Surface Adhesion Marker Expression in Natalizumab Population With Active Control
Observational COMPLETED - - Multiple Sclerosis
NCT00464074
Evaluation of Natalizumab for thE Relief of MS Associated FatiGue
Observational COMPLETED - - Multiple Sclerosis
Company Intelligence
Company profile enrichment is not available yet.

Hiring Intelligence

Latest open positions detected for this company
View All Jobs
No current hiring positions found.
FDA Regulatory Intelligence
FDA product and regulatory signals
0 Signals
No FDA regulatory data available.